.png)
.png)
Assistant Professor
Fred Hutchinson Cancer Center; University of Washington
Disclosure(s): Allovir: Advisor/Consultant, Grant/Research Support; Covance/CSL: Advisor/Consultant; CRISPR: Advisor/Consultant; Deverra: Grant/Research Support; Gilead: Grant/Research Support; Karius: Advisor/Consultant, Grant/Research Support; Merck: Grant/Research Support; Octapharma: Advisor/Consultant; OptumHealth: Advisor/Consultant; Oxford Immunotec: Grant/Research Support; Pfizer: Advisor/Consultant; Symbio: Advisor/Consultant; Takeda: Advisor/Consultant
Dr. Joshua A. Hill is an Assistant Professor at the Fred Hutchinson Cancer Center (FHCC) and an Associate Professor at the University of Washington (UW). His research program is focused on clinical and translational studies to improve preventive and treatment strategies for infections in patients receiving hematopoietic cell transplantations (HCT) and CAR-T cell therapies. Dr. Hill trained in Transplant Infectious Diseases at FHCC and epidemiology/biostatics at the Harvard School of Public Health. He serves as an attending physician on the Immunocompromised Host Infectious Diseases Service at the FHCC and UW Medical Center.